IP Library Granted Patent US 8,889,884
Granted Patent B1
US 8,889,884 · App. 13/546,483 · Granted Nov 18, 2014

Phosphine derivatives of fluorescent compounds

Inventors: Greg Hermanson (Loves Park, IL); Peter T. Czerney (Weimar, DE); Surbhi Desai (Rockford, IL); Suk J. Hong (Roscoe, IL); Matthias S. Wenzel (Jena, DE); Boguslawa Dworecki (Rockford, IL); Frank G. Lehmann (Jena, DE)
Assignees: Pierce Biotechnology, Inc.; Dyomics GmbH
C07F9/535
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,889,884
App. No.
13/546,483
Granted
Nov 18, 2014
Kind
B1
Abstract

A phosphine derivative of DyLight dyes modified with ethylene glycol or (poly)ethylene glycol groups. In one embodiment, the compounds are useful in chemoselective ligation reactions.

Claims (36)

1. A compound of general formula III

where

each of R 1 , R 2 , R 5 , and R 6 is the same or different and is independently selected from the group consisting of an aliphatic, heteroaliphatic, sulfoalkyl group, or heteroaliphatic with terminal SO 3 ;

each of R 7 and R 8 is the same or different and is independently selected from either H, SO 3 , sulfoalkyl, heteroaliphatic, or heteroaliphatic with terminal SO 3 ;

each of R9 and R10 is the same or different and is independently selected from either aryl groups, substituted aryl groups, or cycloalkyl groups;

R11 is an electrophilic group selected from the group consisting of a carboxylic acid, an alkyl ester, an aryl ester, a substituted aryl ester, an aldehyde, and amide, an aryl amide, an alkyl halide, a thioester, a sulfonyl ester, and alkyl ketone, an aryl ketone, a substituted aryl ketone, a halosulfonyl, a nitrile, and a nitro;

L is a linking group selected from the group consisting of a divalent linear (—(CH 2 ) o —, o=1 to 15), crossed, cyclic, and combinations thereof alkylene group which can be substituted by at least one atom selected from the group consisting of oxygen, substituted nitrogen, and sulfur;

Kat is a number of Na + , K + , Ca 2+ , ammonia, or other cation(s) needed to compensate the negative charge brought by the cyanine;

m is an integer from 0 to 5 inclusive; o is an integer from 0 to 12 inclusive; and n is an integer from 1 to 3 inclusive.

2. A compound of general formula IV

where

each of R 1 , R 2 , R 5 , and R 6 is the same or different and is independently selected from the group consisting of an aliphatic, heteroaliphatic, sulfoalkyl group, or heteroaliphatic with terminal SO 3 ;

each of R 7 and R 8 is the same or different and is independently selected from either H, SO 3 , sulfoalkyl, heteroaliphatic, or heteroaliphatic with terminal SO 3 ;

each of R9 and R10 is the same or different and is independently selected from either aryl groups, substituted aryl groups, or cycloalkyl groups;

R11 is an electrophilic group selected from the group consisting of a carboxylic acid, an alkyl ester, an aryl ester, a substituted aryl ester, an aldehyde, and amide, an aryl amide, an alkyl halide, a thioester, a sulfonyl ester, and alkyl ketone, an aryl ketone, a substituted aryl ketone, a halosulfonyl, a nitrile, and a nitro;

L is a linking group selected from the group consisting of a divalent linear (—(CH 2 ) o —, o=1 to 15), crossed, cyclic, and combinations thereof alkylene group which can be substituted by at least one atom selected from the group consisting of oxygen, substituted nitrogen, and sulfur;

Kat is a number of Na + , K + , Ca 2+ , ammonia, or other cation(s) needed to compensate the negative charge brought by the cyanine;

m is an integer from 0 to 5 inclusive; p is an integer from 1 to 6 inclusive; and n is an integer from 1 to 3 inclusive.

3. A compound of formula

4. A compound of formula

5. A compound of formula

6. A method using the compound of claim 1 in a chemoselective ligation reaction with an azido compound.

7. A method using the compound of claim 2 in a chemoselective ligation reaction with an azido compound.

8. A method using the compound of claim 3 in a chemoselective ligation reaction with an azido compound.

9. A method using the compound of claim 4 in a chemoselective ligation reaction with an azido compound.

10. A method using the compound of claim 5 in a chemoselective ligation reaction with an azido compound.

11. A method of labeling at least one biomolecule, the method comprising providing a composition comprising at least one excipient and the compound of claim 1 in an effective concentration to the biomolecule under conditions sufficient for specifically binding the compound to the biomolecule, in the absence of non-specific binding, resulting in labeling of the biomolecule.

12. A method of labeling at least one biomolecule, the method comprising providing a composition comprising at least one excipient and the compound of claim 2 in an effective concentration to the biomolecule under conditions sufficient for specifically binding the compound to the biomolecule, in the absence of non-specific binding, resulting in labeling of the biomolecule.

13. The method of claim 11 further comprising reacting a linking moiety with the at least one biomolecule to result in an at least one biomolecule-linking moiety conjugate, and reacting the compound with the at least one biomolecule-linking moiety conjugate to result in an at least one biomolecule-linking moiety-compound conjugate.

14. The method of claim 12 further comprising reacting a linking moiety with the at least one biomolecule to result in an at least one biomolecule-linking moiety conjugate, and reacting the compound with the at least one biomolecule-linking moiety conjugate to result in an at least one biomolecule-linking moiety-compound conjugate.

15. The method of claim 13 where the linking moiety is a heterobifunctional linking moiety having a first terminal group reactive with an amine group and a second terminal azide.

16. The method of claim 14 where the linking moiety comprises a polyethylene glycol (PEG) group between the first and the second functional termini.

17. A method of detecting at least one biomolecule, the method comprising providing a composition comprising at least one excipient and the compound of claim 1 in an effective concentration to at least one biomolecule under conditions sufficient for binding the compound to the biomolecule, and detecting the biomolecule-bound compound.

18. A method of detecting at least one biomolecule, the method comprising providing a composition comprising at least one excipient and the compound of claim 2 in an effective concentration to at least one biomolecule under conditions sufficient for binding the compound to the biomolecule, and detecting the biomolecule-bound compound.

19. A kit comprising a compound of claim 1 and instructions for performing a chemoselective ligation reaction using the compound with an azido compound.

20. A kit comprising a compound of claim 2 and instructions for performing a chemoselective ligation reaction using the compound with an azido compound.

Assignments (2)
MERGER Recorded Mar 11, 2026
From: PIERCE BIOTECHNOLOGY, INC.
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 075052/0213 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2012
From: HERMANSON, GREG; CZERNEY, PETER T.; DESAI, SURBHI; HONG, SUK J.; WENZEL, MATTHIAS S.; DWORECKI, BOGUSLAWA; LEHMANN, FRANK G.
To: PIERCE BIOTECHNOLOGY, INC.; DYOMICS GMBH
Reel/Frame 028944/0439 →
Continuity (1)
Provisional Application 61507742 · Jul 14, 2011